 |
Top 46 medical and healthcare startups in China
Sep 28, 2025 | By Jason Kwon | 29 |
1
Funding: $272.9M
Chinese smartphone app that lets users remotely consult with physicians to diagnose their ailments
Chinese smartphone app that lets users remotely consult with physicians to diagnose their ailments
2
Funding: CN¥576M
Chenglian Technology is a high-tech enterprise that focuses on the digital manufacturing of the whole process of dentistry.
Chenglian Technology is a high-tech enterprise that focuses on the digital manufacturing of the whole process of dentistry.
3
Funding: $504.7M
Ascentage Pharma is a China-based, global-oriented, clinical-stage biopharmaceutical company, dedicated to discovery and development of the “first-in-class” and the “best-in-class” targeted small-molecule cancer therapeutics.
Ascentage Pharma is a China-based, global-oriented, clinical-stage biopharmaceutical company, dedicated to discovery and development of the “first-in-class” and the “best-in-class” targeted small-molecule cancer therapeutics.
4
Funding: $180M
Adagene is an anticancer antibody discovery and engineering company which seeks to establish technology-driven discovery partnerships.
Adagene is an anticancer antibody discovery and engineering company which seeks to establish technology-driven discovery partnerships.
5
Funding: $1.5B
WeDoctor Group is an online healthcare service provider through its mobile apps and Guahao online portal
WeDoctor Group is an online healthcare service provider through its mobile apps and Guahao online portal
6
Funding: $1.4B
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics.
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics.
7
Funding: $920.3M
MediTrust Health is a leading medical innovation payment service brand in China.
MediTrust Health is a leading medical innovation payment service brand in China.
8
Funding: $737.6M
Rakuten Aspyrian is developing tumor-targeted precision therapies based on its proprietary platform Photoimmunotherapy.
Rakuten Aspyrian is developing tumor-targeted precision therapies based on its proprietary platform Photoimmunotherapy.
9
Funding: $682M
DXY is an online healthcare community for doctors, consumers, and healthcare organizations.
DXY is an online healthcare community for doctors, consumers, and healthcare organizations.
10
Funding: $631.7M
Waterdrop is an online insurance technology platform that plans to solve the problem of high medical fees faced by many patients.
Waterdrop is an online insurance technology platform that plans to solve the problem of high medical fees faced by many patients.
11
Funding: $343.7M
Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing novel and transformative biologic therapies.
Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing novel and transformative biologic therapies.
12
Funding: $312.8M
Harbour BioMed is a global biopharmaceutical company developing innovative therapeutics in the field of immuno-oncology and inflammatory diseases.
Harbour BioMed is a global biopharmaceutical company developing innovative therapeutics in the field of immuno-oncology and inflammatory diseases.
13
Funding: $288.8M
Tianjin CanSino Biotech is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.
Tianjin CanSino Biotech is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.
14
Funding: $276M
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.
15
Funding: $262M
D3 Bio identifies areas of unmet need in immunology and oncology and use existing clinical data to find precision medicine targets and delivery methods with the potential to improve outcomes.
D3 Bio identifies areas of unmet need in immunology and oncology and use existing clinical data to find precision medicine targets and delivery methods with the potential to improve outcomes.
16
Funding: $220M
Dingdang Health’s online-to-offline model enables it to supply drugs from the pharma manufacturers and offline pharmacies to meet users’ urgent medical needs.
Dingdang Health’s online-to-offline model enables it to supply drugs from the pharma manufacturers and offline pharmacies to meet users’ urgent medical needs.
17
Funding: $214.7M
Beijing Infervision is an artificial intelligence high-tech company committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions. Infervision effectively uses various types of medical data to create clinically valued products and promotes precision analysis in the medical field especially in assisted image diagnosis.
Beijing Infervision is an artificial intelligence high-tech company committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions. Infervision effectively uses various types of medical data to create clinically valued products and promotes precision analysis in the medical field especially in assisted image diagnosis.
18
Funding: $200M
iCarbonX aims to build an ecosystem of digital life based on a combination of an individual’s biological, behavioral and psychological data, the Internet and artificial intelligence.
iCarbonX aims to build an ecosystem of digital life based on a combination of an individual’s biological, behavioral and psychological data, the Internet and artificial intelligence.
19
Funding: $195M
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
20
Funding: $190M
JW is focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer.
JW is focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer.
